Keyphrases
Ischemia
100%
Protective Effect
100%
Dysregulation
100%
Ischemia Injury
100%
Ischemia-reperfusion Injury
100%
Reperfusion
100%
Kidney
100%
Inducible Nitric Oxide Synthase
42%
Renal Medulla
42%
Chronic Kidney Disease
28%
Inflammation
28%
Inducible Nitric Oxide Synthase Inhibitors
28%
Acute Kidney Injury
28%
Cell Cycle Arrest
28%
Endothelial Activation
28%
Renal Reperfusion
28%
Mesenchymal Transition
28%
Renal Ischemia
28%
Therapeutic Blockade
28%
Renal Function
14%
Kidney Disease
14%
Sham
14%
Blood Urea Nitrogen
14%
Medulla
14%
Blood Pressure
14%
Serum Creatinine
14%
Adverse Effects
14%
Detrimental Effects
14%
Fibrosis
14%
Endothelial Dysfunction
14%
Nitric Oxide
14%
Negative Effects
14%
High Mortality
14%
Drug Administration
14%
Therapeutic Strategies
14%
Disease Conditions
14%
Blood Flow
14%
Kidney Ischemia
14%
Kidney Injury
14%
Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL)
14%
Low Toxicity
14%
High Morbidity
14%
Pharmacological Strategies
14%
Proliferating Cell nuclear Antigen
14%
Aberrant Gene Expression
14%
Global Health Issue
14%
Tissue Injury
14%
Balb C Mice
14%
Therapeutic Limitations
14%
Medicine and Dentistry
Ischemia
100%
Reperfusion Injury
100%
N [3 (Aminomethyl)benzyl]acetamidine
100%
Inducible Nitric Oxide Synthase
50%
Medulla
40%
Kidney Ischemia
30%
Acute Kidney Injury
20%
Cell Cycle Arrest
20%
Nitric Oxide Synthase Inhibitor
20%
Cell Cycle Checkpoint
20%
Disease
10%
Adverse Event
10%
Kidney Function
10%
Kidney Dysfunction
10%
Blood Urea Nitrogen
10%
Creatinine
10%
Blood Pressure
10%
Fibrosis
10%
Chronic Kidney Disease
10%
Endothelial Dysfunction
10%
Gene Expression
10%
Nephropathy
10%
Tissue Injury
10%
Drug Administration
10%
Upregulation
10%
Blood Flow
10%
Nitric Oxide
10%
Kidney Injury
10%
Neutrophil Gelatinase Associated Lipocalin
10%
Acute Renal Failure
10%
Proliferating Cell Nuclear Antigen
10%
Messenger RNA
10%
Pharmacology, Toxicology and Pharmaceutical Science
Ischemia
100%
Reperfusion Injury
100%
N [3 (Aminomethyl)benzyl]acetamidine
100%
Inducible Nitric Oxide Synthase
50%
Kidney Ischemia
30%
Acute Kidney Failure
20%
Inflammation
20%
Nitric Oxide Synthase Inhibitor
20%
Chronic Kidney Failure
10%
Disease
10%
Kidney Dysfunction
10%
Creatinine
10%
Ureaplasma
10%
Adverse Event
10%
Endothelial Dysfunction
10%
Tissue Injury
10%
Drug Administration
10%
Nitric Oxide
10%
Kidney Injury
10%
Neutrophil Gelatinase Associated Lipocalin
10%
Fibrosis
10%
Kidney Disease
10%
Cycline
10%
Bagg Albino Mouse
10%
Messenger RNA
10%